DK569687D0 - Ifosfamidlyofilisat og fremgangsmaade til dets fremstilling - Google Patents

Ifosfamidlyofilisat og fremgangsmaade til dets fremstilling

Info

Publication number
DK569687D0
DK569687D0 DK569687A DK569687A DK569687D0 DK 569687 D0 DK569687 D0 DK 569687D0 DK 569687 A DK569687 A DK 569687A DK 569687 A DK569687 A DK 569687A DK 569687 D0 DK569687 D0 DK 569687D0
Authority
DK
Denmark
Prior art keywords
lyphilizate
ifosphamide
procedure
preparation
ifosfamide
Prior art date
Application number
DK569687A
Other languages
English (en)
Other versions
DK569687A (da
DK169308B1 (da
Inventor
Dieter Sauerbier
Uwe-Peter Dammann
Otto Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of DK569687D0 publication Critical patent/DK569687D0/da
Publication of DK569687A publication Critical patent/DK569687A/da
Application granted granted Critical
Publication of DK169308B1 publication Critical patent/DK169308B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Control Of El Displays (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Indole Compounds (AREA)
  • Amplifiers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK569687A 1986-10-31 1987-10-30 Lyofiliseret præparat, fremgangsmåde til fremstilling af et ifosfamidlyofilisatpræparat samt ifosfamidlyofilisatpræparatet opnået ved fremgangsmåden DK169308B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31
DE3637089 1986-10-31

Publications (3)

Publication Number Publication Date
DK569687D0 true DK569687D0 (da) 1987-10-30
DK569687A DK569687A (da) 1988-05-01
DK169308B1 DK169308B1 (da) 1994-10-10

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
DK569687A DK169308B1 (da) 1986-10-31 1987-10-30 Lyofiliseret præparat, fremgangsmåde til fremstilling af et ifosfamidlyofilisatpræparat samt ifosfamidlyofilisatpræparatet opnået ved fremgangsmåden

Country Status (25)

Country Link
EP (1) EP0265812B1 (da)
JP (1) JPS63159319A (da)
KR (1) KR900003491B1 (da)
AT (1) ATE55250T1 (da)
AU (1) AU598602B2 (da)
CA (1) CA1314231C (da)
DD (1) DD262582A5 (da)
DE (1) DE3764235D1 (da)
DK (1) DK169308B1 (da)
EG (1) EG18333A (da)
ES (1) ES2017982B3 (da)
FI (1) FI87140C (da)
GE (1) GEP19971025B (da)
GR (1) GR3000708T3 (da)
HU (1) HU197987B (da)
IL (1) IL84312A (da)
IN (1) IN168119B (da)
LV (1) LV10051B (da)
MX (1) MX8958A (da)
NO (1) NO873860L (da)
PT (1) PT86032B (da)
RU (1) RU1836079C (da)
UA (1) UA11075A (da)
YU (1) YU197387A (da)
ZA (1) ZA878183B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58900183D1 (de) * 1988-03-19 1991-08-29 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
NZ506578A (en) * 1998-03-03 2003-09-26 Shionogi & Co Pharmaceutical compositions containing the phospholipase inhibitor sodium [[3-(2-amino-1,2-dioxoethyl)- 2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate
CA2497898C (en) * 2002-09-05 2012-02-07 Bharat Serums & Vaccines Ltd. Liquid stable composition of oxazaphosphorine with mesna
BR0316968A (pt) * 2002-12-02 2005-10-25 Bharat Serums & Vaccines Ltd Composições estáveis, claras, aquosas de ifosfamida para administração parenteral que apresentam pouca toxicidade; processo para a preparação de composições de ifosfamida; e composições de ifosfamida e um processo para a preparação das mesmas
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
MX2009003197A (es) * 2006-09-29 2009-05-08 Infa Sa Sistema de embalaje para composiciones farmaceuticas y equipo para administracion intravenosa.
WO2016087001A1 (en) * 2014-12-04 2016-06-09 Huawei Technologies Co., Ltd. Load allocation in a data communication network

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (de) * 1977-05-09 1978-11-16 Walton J Smith Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung
DE3279834D1 (en) * 1981-12-31 1989-08-31 Asta Pharma Ag 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
FI874727A0 (fi) 1987-10-27
ES2017982B3 (es) 1991-03-16
AU8052987A (en) 1988-05-05
EG18333A (en) 1993-12-30
GR3000708T3 (en) 1991-10-10
NO873860L (no) 1988-05-02
EP0265812B1 (de) 1990-08-08
MX8958A (es) 1993-12-01
LV10051B (en) 1995-06-20
IN168119B (da) 1991-02-09
UA11075A (uk) 1996-12-25
KR900003491B1 (ko) 1990-05-21
DE3764235D1 (de) 1990-09-13
KR880004814A (ko) 1988-06-27
YU197387A (en) 1988-12-31
LV10051A (lv) 1994-05-10
PT86032B (pt) 1990-08-31
FI874727A (fi) 1988-05-01
DK569687A (da) 1988-05-01
HU197987B (en) 1989-07-28
AU598602B2 (en) 1990-06-28
IL84312A (en) 1991-11-21
DK169308B1 (da) 1994-10-10
RU1836079C (ru) 1993-08-23
DD262582A5 (de) 1988-12-07
NO873860D0 (no) 1987-09-15
IL84312A0 (en) 1988-03-31
JPH0543684B2 (da) 1993-07-02
GEP19971025B (en) 1997-04-06
ZA878183B (en) 1988-05-02
HUT44932A (en) 1988-05-30
FI87140C (fi) 1992-12-10
ATE55250T1 (de) 1990-08-15
FI87140B (fi) 1992-08-31
CA1314231C (en) 1993-03-09
EP0265812A1 (de) 1988-05-04
PT86032A (de) 1987-11-01
JPS63159319A (ja) 1988-07-02

Similar Documents

Publication Publication Date Title
NO900528D0 (no) Anthelmintika, fremgangsmaate for fremstilling derav, og preparat med et innhold derav.
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
PT90030A (pt) Processo para a preparacao de liofilisado de ifosfamida e mesna
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
ES557152A0 (es) Un procedimiento para preparar laudanos
DK569687A (da) Ifosfamidlyofilisat og fremgangsmaade til dets fremstilling
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
NO881308D0 (no) Dihydropyridinamider, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
DK103987A (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
NO871481D0 (no) Substituerte tiacykloalkeno(3,2-b)pyridiner og fremgangsmaate for deres fremstilling.
NZ219623A (en) N-(heterocyclic-substituted phenyl)-n'-benzoylurea derivatives and pesticidal compositions
DK164906C (da) Isothiourinstof-derivat og fremgangsmaade til fremstilling deraf
DK574588A (da) Laegemiddel til mennesker og dyr med antiviral og antitumoral virkning samt fremgangsmaade til fremstilling deraf
NO880639D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner.
NO164539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 5-nafthyl-2,4-dimethyl-3h-1,2,4-triazol-3-thion.
IT1173551B (it) Derivato del p-aminofenolo con attivita' mucosecretolitica-fluidificante e antipiretica,procedimento per la sua preparazione e sue composizioni farmaceutiche

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired